Rifampicin-Loaded Mesoporous Silica Nanoparticles for the Treatment of Intracellular Infections

Infectious diseases remain a major burden in today’s world, causing high mortality rates and significant economic losses, with >9 million deaths per year predicted by 2030. Invasion of host cells by intracellular bacteria poses treatment challenges due to the poor permeation of antimicrobials int...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramaniam, Santhni, Thomas, Nicky, Gustafsson, Hanna, Jambhrunkar, Manasi, Kidd, Stephen P., Prestidge, Clive A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628058/
https://www.ncbi.nlm.nih.gov/pubmed/30979069
http://dx.doi.org/10.3390/antibiotics8020039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628058/
https://www.ncbi.nlm.nih.gov/pubmed/30979069
http://dx.doi.org/10.3390/antibiotics8020039

Ejemplares similares